The best-known GLP-1, backed by extensive diabetes, weight-management, and cardiovascular evidence.
Vial
10 mg
BAC Water
2 mL
Dose
250 mcg
Units on 1 mL
5
Timing
AM
Frequency
1x per week
Duration
Until goal weight
Note: Start 250mcg weekly for 4 weeks, then titrate: 500mcg → 1mg → 1.7mg → 2.4mg max. Most vendors ship 10mg vials.
Also sold as
Research chemical vendors can't legally label products with the real name, so Semaglutide often appears under coded SKUs. If you're shopping and see any of these, it's the same compound:
GLP-1
GLP1
Sema
Branch-1S· Branch Peptides
Ion-1S· Ion Peptides
Ozempic (Rx)
Wegovy (Rx)
Codes shown are for identification only. Always verify third-party COAs before purchase.
Your draw
5 units · 250 mcg
On a standard 100-unit / 1 mL insulin syringe.
What it actually is
Semaglutide is a long-acting GLP-1 receptor agonist used in approved prescription products including Ozempic, Wegovy, and Rybelsus. It increases glucose-dependent insulin release, reduces glucagon when glucose is elevated, slows gastric emptying, and influences appetite centers in the brain. The brand, dose, route, and indication matter: weekly diabetes dosing, weekly weight-management dosing, and oral semaglutide are not interchangeable instructions.
Dose escalation is intentionally gradual because nausea, constipation, diarrhea, reflux, and reduced appetite often increase after a dose change. Product labeling also includes important contraindications and warnings, including personal or family history of medullary thyroid carcinoma or MEN2.
Why people use it
Type 2 diabetes treatment with strong A1C and fasting-glucose evidence
Chronic weight management when prescribed under the appropriate indication
Cardiovascular risk reduction in specific higher-risk populations supported by outcome trials
A large evidence base and longer real-world history than newer dual or triple agonists
Educational only · Not a vendor claim
How it works
Mimics GLP-1 for prolonged receptor activity. It increases glucose-dependent insulin release, suppresses inappropriate glucagon, slows gastric emptying, and reduces appetite through central satiety signaling.
Health benefits
Strong A1C and glucose-control evidence
Average weight reduction around 15% in a major 68-week obesity trial at the studied dose
Cardiovascular outcome benefits in eligible populations
Approved weekly injection and oral formulations for specific indications
What you'll feel
Less hunger and reduced food noise
Earlier fullness and smaller portions
Steady rather than instant weight change
Effects may weaken if treatment is discontinued
Pros
Largest and most mature evidence base of these three
Approved products with standardized labeling
Once-weekly injection option
Established cardiovascular outcomes data
Cons
GI effects can limit escalation
Weight regain is common after stopping
Lean mass can fall along with fat mass
Different brands and formulations are not interchangeable
Evidence-focused GLP-1 educationType 2 diabetes discussionsChronic weight-management discussionsPeople prioritizing the longest track record of the three
Educational summary · Not medical advice · Discuss with a qualified clinician
What to expect
Typical timeline
General pattern for the Fat Loss category. Individual response varies.
Week 1
Titrate up slowly. Expect appetite drop, mild nausea, and possible constipation with GLP-1s. Hydrate and lean on fiber.
Weeks 2–4
Steady weight trend down (0.5–1.5 lb/week is healthy). Prioritize protein (~1 g/lb lean mass) to protect muscle.
Weeks 4–8
Body composition visibly shifts. Add resistance training if you haven't — muscle preservation is the whole game.
Weeks 8+
Re-evaluate dose. Consider a maintenance drop or a scheduled break to reset receptor sensitivity.
Stacking partners
Pairs well with
Common combinations experienced users run alongside Semaglutide. Always add one peptide at a time so you can attribute effects and side effects.
1Reconstitute the 10 mg vial with 2 mL of bacteriostatic water. Tilt — don't shake.
2Concentration becomes 5,000 mcg/mL (5 mg/mL).
3For a 250 mcg dose, draw 0.050 mL — that's 5 units on a 1 mL insulin syringe.
4One vial gives you approximately 40 doses.
Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.
Dose log
Sign in to keep a private log of your doses and notes for Semaglutide.